TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
HRTX

Heron Therapeuti

Healthcare · Biotechnology

0.3157$ -0.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Heron Therapeuti (HRTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 155 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HRTX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 1.3 31 77 146 89 86 108 127 144 155
55 61 0.0 4.6 28 62 36 46 55 65 39 41
-55 -61 1.2 26 50 84 52 40 53 62 106 114
55 61 103 139 140 167 175 131 108 39 17 12
20 36 21 26 29 38 42 40 37 58 53 55
75 97 172 221 234 295 281 258 227 173 117 116
-75 -97 -171 -195 -184 -211 -228 -218 -175 -111 -12 -2.5
0.9 1.0 2.7 3.9 2.7 1.5 1.9 2.4 2.5 3.9 6.0 9.6
-76 -98 -173 -197 -179 -205 -227 -221 -182 -111 -14 -20
-0.6 -0.7 -1.1 3.9 7.8 1.9 -2.8 -3.0 -48 2.7
-76 -98 -173 -197 -179 -205 -224 -218 -135 -111 -14 -20
-74 -96 -170 -192 -182 -201 -225 -215 -172 -104 -5.1 -18

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?